Dichloro[2-(4,5-dihydro-2-oxazolyl)quinoline]palladium(II)
Product Information
Molecular Formula
C12H10Cl2N2OPd
Molecular Weight
375.55
Description
Dichloro[2-(4,5-dihydro-2-oxazolyl)quinoline]palladium(II) is an invaluable compound widely employed in the field of biomedicine. This compound displays remarkable potential in the advancement of anti-neoplastic agents owing to its proficient ability to selectively target malignant cells. Notably, this intricate compound has exhibited promising outcomes in the drug development of an array of malignancies, encompassing breast, lung, and prostate cancer. Its mode of action precisely involves the binding to specified cellular receptors, thereby impeding tumor growth and hampering uncontrolled proliferative activity. Additionally, the distinctive structural attributes of this compound render it an optimal candidate warranting extensive exploration in the realm of cancer therapy.
Synonyms
Pd(quinox)Cl2
IUPAC Name
dichloropalladium2-quinolin-2-yl-4,5-dihydro-1,3-oxazole
SMILES
C1COC(=N1)C2=NC3=CC=CC=C3C=C2.Cl[Pd]Cl
InChI
InChI=1S/C12H10N2O.2ClH.Pd/c1-2-4-10-9(3-1)5-6-11(14-10)12-13-7-8-15-12;;;/h1-6H,7-8H2;2*1H;/q;;;+2/p-2
InChI Key
DQWIOWASGZSKNG-UHFFFAOYSA-L
Flash Point
Not applicable
Purity
95%
Safety Information
Hazards
H302 - H315 - H317 - H318
Precautionary Statement
P280 - P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 + P310
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
1
Exact Mass
373.92050 g/mol
Monoisotopic Mass
373.92050 g/mol
Topological Polar Surface Area
34.5Ų
Heavy Atom Count
18
Formal Charge
0
Complexity
267
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021062035-A1 | Luminescent materials and methods thereof | 2019-09-27 |
| KR-20200020877-A | Methods and intermediates for the preparation of bile acid derivatives | 2017-06-23 |
| US-2018371009-A1 | Methods and intermediates for the preparation of bile acid derivatives | 2017-06-23 |
| BR-112019027458-A2 | methods and intermediates for the preparation of bile acid derivatives | 2017-06-23 |
| JP-2020525426-A | Methods and intermediates for the preparation of bile acid derivatives | 2017-06-23 |
| US-11066437-B2 | Methods and intermediates for the preparation of bile acid derivatives | 2017-06-23 |
| CN-106565640-A | Solanesol furan spice substitute and synthesis method thereof | 2016-11-12 |
| JP-2016220628-A | Microorganism detection method and microorganism detection kit | 2015-05-29 |
| JP-6537894-B2 | Microorganism detection method and microorganism detection kit | 2015-05-29 |
| AU-2015274967-A1 | Processes for preparing antiviral compounds | 2014-06-11 |
